- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 07-06-2025: Press Release
07-06-2025 | 04:46 pm
07-06-2025 | 04:46 pm
Lupin has announced a board meeting to approve the financial results for the quarter and half-year. The company received tentative approval from the U.S. FDA for Oxcarbazepine Extended-Release Tablets, targeting a US market worth USD 206 million annually. Manufactured at Lupin’s Nagpur plant, this launch boosts their CNS portfolio and strengthens US market presence.
No comments yet. Be the first to comment!